#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Systemic scleroderma+3

Recruiting

Registered drugNo placebo

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Arteriosclerosis

Recruiting

InvestigationalNo placebo

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Pelacarsen

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

IgA nephropathy

Recruiting

Registered drug

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter

Recruiting

InvestigationalNo placebo

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Mitomycin

Contact Research Centre

Atrial fibrillation

Recruiting

Investigational

Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:AP31969 SULFATE

Contact Research Centre

Chronic hepatitis B

Recruiting

Registered drug

Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:ALG-000184

Contact Research Centre

Major depression

Recruiting

Investigational

Study of NBI-1065845 as add-on treatment to prevent depression relapse in adults with Major Depressive Disorder who responded to initial treatment

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Hypertriglyceridaemia

Recruiting

Investigational

Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues

Contact Research Centre

Asthma

Recruiting

Investigational

Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Acromegaly

Recruiting

Registered drug

Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.